Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: Sanofi
Colitis Ulcerative
United States, Argentina, Canada, Chile, Japan +6 more
Sponsor: Toray Industries, Inc
Gastric Adenocarcinoma · Gastric Cancer · Gastroesophageal Junction Adenocarcinoma
United States, Japan, South Korea
Sponsor: AstraZeneca
Ulcerative Colitis · IBD
United States, Canada, Czechia, Germany, Hungary +14 more
- Tocilizumab in Refractory ASS-ILDCompleted
Sponsor: Hu Yinan
Antisynthetase Syndrome · Tocilizumab
China
Sponsor: Sanofi
Solid Tumor
United States, Chile, Israel, Japan, Netherlands +1 more
- Roll-over Study to Allow Continued Access to RibociclibActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Metastatic Breast Cancer
United States, Argentina, Brazil, China, Costa Rica +17 more
Sponsor: Genzyme, a Sanofi Company
Fabry Disease
United States, Argentina, Australia, Belgium, Brazil +39 more
- Phase 2 Study of Rapcabtagene Autoleucel in MyositisActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Idiopathic Inflammatory Myopathies
United States, Australia, Brazil, France, Germany +10 more
- Pompe Disease Registry ProtocolRecruiting
Sponsor: Genzyme, a Sanofi Company
Glycogen Storage Disease Type II · Pompe Disease
United States, Argentina, Australia, Belgium, Brazil +39 more
- A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and OverweightActive Not Recruiting
Sponsor: AstraZeneca
Overweight and Obesity
Austria, Canada, Germany, Japan, Sweden
- A Long-Term Safety Study of PTC923 in Participants With PhenylketonuriaActive Not Recruiting
Sponsor: PTC Therapeutics
Phenylketonuria
United States, Australia, Brazil, Canada, Czechia +14 more
- A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)Recruiting
Sponsor: GlaxoSmithKline
Systemic Lupus Erythematosus
Argentina, Brazil, France, Italy, Japan +4 more
Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd.
Respiratory Syncytial Virus Infections
China
- A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial CancerActive Not Recruiting
Sponsor: Eli Lilly and Company
Breast Cancer · Advanced Breast Cancer · Metastatic Breast Cancer · Endometrial Cancer
United States, Australia, Belgium, France, Japan +3 more
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Migraine Disorders
Japan
- Linerixibat Long-term Safety, and Tolerability StudyActive Not Recruiting
Sponsor: GlaxoSmithKline
Cholestasis
United States, Argentina, Brazil, Bulgaria, Canada +12 more
Sponsor: Takeda
Ulcerative Colitis · Crohn's Disease
United States, Belgium, Bulgaria, Denmark, Ireland +11 more
Sponsor: Celgene
Multiple Myeloma
United States, Belgium, Canada, France, Germany +8 more
- Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)Active Not Recruiting
Sponsor: Alexion Pharmaceuticals, Inc.
Immunoglobulin A Nephropathy · IgAN
United States, Argentina, Australia, Austria, Belgium +23 more
- Samsca Post-marketing General Drug Use-results Survey in Patients With Hyponatremia in SIADHActive Not Recruiting
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Antidiuretic Hormone, Inappropriate Secretion
Japan
- Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis ImperfectaRecruiting
Sponsor: Amgen
Osteogenesis Imperfecta
United States, Germany, Japan
- Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase AlfaActive Not Recruiting
Sponsor: Alexion Pharmaceuticals, Inc.
Hypophosphatasia
United States, Argentina, Australia, Brazil, Canada +12 more
- A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid TumorsActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Mesothelioma
United States, Australia, Canada, France, Germany +6 more
- A Study of Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection.Recruiting
Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd.
Respiratory Syncytial Virus Infections
China
Sponsor: Novartis Pharmaceuticals
Polymyalgia Rheumatica
United States, Argentina, Australia, Belgium, Brazil +21 more